www.magazine-industry-usa.com
10
'25
Written on Modified on
Stryker launches Incompass Total Ankle System at AOFAS 2025
Incompass includes 3D-printed porous metal tibial and talar components engineered to promote early bony ingrowth, often as early as four weeks.
www.stryker.com
Stryker, a global leader in medical technologies, will launch its Incompass™ Total Ankle System at the 2025 American Orthopaedic Foot & Ankle Society (AOFAS) Annual Meeting in Savannah, Georgia, September 10–13, 2025 (booth # 401). The FDA-cleared system is intended for patients with end-stage ankle arthritis and introduces an innovative implant with an enhanced instrument platform.
Incompass provides a comprehensive approach to total ankle replacement. It was developed to mimic Stryker’s Infinity and Inbone with a similar implant profile, fixation and sulcus articulation. Leveraging these two legacy designs, Stryker created Incompass, aiming to advance clinical performance, address evolving surgeon needs and deliver meaningful value to hospitals and patients. Both legacy systems have documented five-year survivorship rates of 98% or higher.
The system offers intraoperative flexibility, enabling surgeons to adjust implant configurations in real time to support patient-specific needs. Incompass includes 3D-printed porous metal tibial and talar components engineered to promote early bony ingrowth, often as early as four weeks. By combining implant options and reducing instrumentation, the system helps reduce procedural complexity, enhance decision-making and lower sterilization demands.
The implants were designed using SOMA, Stryker’s Orthopedic Modeling and Analytics tool, which analyzed real patient anatomy from arthritic ankle CT scans in the Prophecy® database. SOMA was used to study bone quality and optimize implant location.
Further insights were gained from more than 80,000 Prophecy scans. The system’s instrumentation was refined with input from a global clinical advisory team of experienced foot and ankle surgeons and informed by more than 100,000 total ankle cases, reinforcing Stryker’s commitment to evidence-based design and long-term patient outcomes.
Visit Booth #401 at AOFAS 2025 to learn more.
www.stryker.com
Incompass provides a comprehensive approach to total ankle replacement. It was developed to mimic Stryker’s Infinity and Inbone with a similar implant profile, fixation and sulcus articulation. Leveraging these two legacy designs, Stryker created Incompass, aiming to advance clinical performance, address evolving surgeon needs and deliver meaningful value to hospitals and patients. Both legacy systems have documented five-year survivorship rates of 98% or higher.
The system offers intraoperative flexibility, enabling surgeons to adjust implant configurations in real time to support patient-specific needs. Incompass includes 3D-printed porous metal tibial and talar components engineered to promote early bony ingrowth, often as early as four weeks. By combining implant options and reducing instrumentation, the system helps reduce procedural complexity, enhance decision-making and lower sterilization demands.
The implants were designed using SOMA, Stryker’s Orthopedic Modeling and Analytics tool, which analyzed real patient anatomy from arthritic ankle CT scans in the Prophecy® database. SOMA was used to study bone quality and optimize implant location.
Further insights were gained from more than 80,000 Prophecy scans. The system’s instrumentation was refined with input from a global clinical advisory team of experienced foot and ankle surgeons and informed by more than 100,000 total ankle cases, reinforcing Stryker’s commitment to evidence-based design and long-term patient outcomes.
Visit Booth #401 at AOFAS 2025 to learn more.
www.stryker.com
